GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $317,000 | -21.7% | 7,273 | -21.7% | 0.02% | -20.7% |
| Q1 2022 | $405,000 | -1.2% | 9,294 | 0.0% | 0.03% | +11.5% |
| Q4 2021 | $410,000 | +30.2% | 9,294 | +12.9% | 0.03% | +23.8% |
| Q3 2021 | $315,000 | -18.4% | 8,230 | -15.1% | 0.02% | -16.0% |
| Q2 2021 | $386,000 | +8.4% | 9,694 | -2.8% | 0.02% | +4.2% |
| Q1 2021 | $356,000 | +559.3% | 9,969 | +584.2% | 0.02% | +380.0% |
| Q4 2020 | $54,000 | +38.5% | 1,457 | +42.0% | 0.01% | +25.0% |
| Q3 2020 | $39,000 | -7.1% | 1,026 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $42,000 | +7.7% | 1,026 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $39,000 | -18.8% | 1,026 | 0.0% | 0.01% | +25.0% |
| Q4 2019 | $48,000 | -7.7% | 1,026 | -16.3% | 0.00% | -20.0% |
| Q3 2019 | $52,000 | +26.8% | 1,226 | +19.5% | 0.01% | +25.0% |
| Q2 2019 | $41,000 | -4.7% | 1,026 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $43,000 | +95.5% | 1,026 | +78.4% | 0.00% | +100.0% |
| Q4 2018 | $22,000 | -26.7% | 575 | -22.9% | 0.00% | -33.3% |
| Q3 2018 | $30,000 | -3.2% | 746 | -3.7% | 0.00% | 0.0% |
| Q2 2018 | $31,000 | +3.3% | 775 | 0.0% | 0.00% | -25.0% |
| Q1 2018 | $30,000 | +11.1% | 775 | 0.0% | 0.00% | +33.3% |
| Q4 2017 | $27,000 | -12.9% | 775 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $31,000 | -51.6% | 775 | -47.5% | 0.00% | -55.6% |
| Q2 2017 | $64,000 | +3.2% | 1,477 | 0.0% | 0.01% | +12.5% |
| Q1 2017 | $62,000 | +8.8% | 1,477 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $57,000 | -39.4% | 1,477 | -32.1% | 0.01% | -38.5% |
| Q3 2016 | $94,000 | +176.5% | 2,176 | +180.8% | 0.01% | +160.0% |
| Q2 2016 | $34,000 | -51.4% | 775 | -55.6% | 0.01% | -64.3% |
| Q1 2016 | $70,000 | 0.0% | 1,745 | 0.0% | 0.01% | -6.7% |
| Q4 2015 | $70,000 | +27.3% | 1,745 | +21.6% | 0.02% | +25.0% |
| Q3 2015 | $55,000 | -6.8% | 1,435 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $59,000 | +3.5% | 1,435 | +16.2% | 0.01% | 0.0% |
| Q1 2015 | $57,000 | -6.6% | 1,235 | -14.2% | 0.01% | -14.3% |
| Q4 2014 | $61,000 | -6.2% | 1,440 | 0.0% | 0.01% | -17.6% |
| Q3 2014 | $65,000 | -43.0% | 1,440 | -32.6% | 0.02% | -43.3% |
| Q2 2014 | $114,000 | 0.0% | 2,135 | 0.0% | 0.03% | -9.1% |
| Q1 2014 | $114,000 | -7.3% | 2,135 | -7.6% | 0.03% | -8.3% |
| Q4 2013 | $123,000 | +16.0% | 2,310 | +9.2% | 0.04% | +12.5% |
| Q3 2013 | $106,000 | -26.4% | 2,115 | -26.6% | 0.03% | -20.0% |
| Q2 2013 | $144,000 | – | 2,880 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |